Oral Pathogens and Their Antibiotics from Marine Organisms: A Systematic Review of New Drugs for Novel Drug Targets

키워드

참고문헌 (95)

1. Takahashi N, "Oral microbiome metabolism : from"who are they?"to"what are they doing?"", J Dent Res, 94, pp.1628~1637 (2015)[DOI]
2. Xu X, "Oral cavity contains distinct niches with dynamic microbial communities", Environ Microbiol, 17, pp.699~710 (2015)[DOI]
3. Bowen WH, "Oral biofilms : pathogens, matrix, and polymicrobial interactions in microenvironments", Trends Microbiol, 26, pp.229~242 (2018)[DOI]
4. Marsh PD, "Microbiology of dental plaque biofilms and their role in oral health and caries", Dent Clin North Am, 54, pp.441~454 (2010)[DOI]
5. Marsh PD, "Dental plaque as a biofilm and a microbial community-implications for health and disease", BMC Oral Health 6 Suppl, 1, pp.S14~ (2006)[DOI]
6. Debelian GJ, "Systemic diseases caused by oral microorganisms", Endod Dent Traumatol, 10, pp.57~65 (1994)[DOI]
7. Beck JD, "Systemic effects of periodontitis : epidemiology of periodontal disease and cardiovascular disease", J Periodontol, 76, pp.2089~2100 (2005)[DOI]
8. Borgnakke WS, "Effect of periodontal disease on diabetes : systematic review of epidemiologic observational evidence", J Clin Periodontol, 40, pp.S135~S152 (2013)[DOI]
9. Olsen I, "Possible role of Porphyromonas gingivalis in orodigestive cancers", J Oral Microbiol, 11, pp.1563410~ (2019)[DOI]
10. Könönen E, "Prevotella species as oral residents and infectious agents with potential impact on systemic conditions", J Oral Microbiol, 14, pp.2079814~ (2022)[DOI]
11. Issrani R, "Exploring the mechanisms and association between oral microflora and systemic diseases", Diagnostics(Basel), 12, pp.2800~ (2022)[DOI]
12. Aas JA, "Bacteria of dental caries in primary and permanent teeth in children and young adults", J Clin Microbiol, 46, pp.1407~1417 (2008)[DOI]
13. Yanagisawa M, "Proteinase activity of Prevotella species associated with oral purulent infection", Curr Microbiol, 52, pp.375~378 (2006)[DOI]
14. Neilands J, "Bacterial profiles and proteolytic activity in peri-implantitis versus healthy sites", Anaerobe, 35, pp.28~34 (2015)[DOI]
15. van Winkelhoff AJ, "Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction", J Clin Periodontol, 29, pp.1023~1028 (2002)[DOI]
16. Bostanci N, "Porphyromonas gingivalis : an invasive and evasive opportunistic oral pathogen", FEMS Microbiol Lett, 333, pp.1~9 (2012)[DOI]
17. Bao K, "Role of Porphyromonas gingivalis gingipains in multi-species biofilm formation", BMC Microbiol, 14, pp.258~ (2014)[DOI]
18. Scannapieco FA, "Role of oral bacteria in respiratory infection", J Periodontol, 70, pp.793~802 (1999)[DOI]
19. Williams D, "Pathogenesis and treatment of oral candidosis", J Oral Microbiol, 3, pp.5771~ (2011)[DOI]
20. Vila T, "Oral candidiasis: a disease of opportunity", J Fungi (Basel), 6, pp.15~ (2020)[DOI]
21. Patil S, "Microbial flora in oral diseases", J Contemp Dent Pract, 14, pp.1202~1208 (2013)[DOI]
22. Deepa A, "Uncommon opportunistic fungal infections of oral cavity : a review", J Oral Maxillofac Pathol, 18, pp.235~243 (2014)[DOI]
23. Seifert HS, "Location, location, location-commensalism, damage and evolution of the pathogenic Neisseria", J Mol Biol, 431, pp.3010~3014 (2019)[DOI]
24. Giacomini JJ, "Spatial ecology of Haemophilus and Aggregatibacter in the human oral cavity", Microbiol Spectr, 12, pp.e0401723~ (2024)[DOI]
25. Jakubovics NS, "The road to ruin : the formation of disease-associated oral biofilms", Oral Dis, 16, pp.729~739 (2010)[DOI]
26. Kolenbrander PE, "Oral multispecies biofilm development and the key role of cell-cell distance", Nat Rev Microbiol, 8, pp.471~480 (2010)[DOI]
27. Hasty DL, "Multiple adhesins of streptococci", Infect Immun, 60, pp.2147~2152 (1992)[DOI]
28. Jakubovics NS, "Functions of cell surface-anchored antigen I", II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors, 2005, pp.73, 6629~6638
29. Jakubovics NS, "Differential binding specificities of oral streptococcal antigen I", II family adhesins for human or bacterial ligands, 2005, pp.55, 1591~1605
30. Llor C, "Antimicrobial resistance : risk associated with antibiotic overuse and initiatives to reduce the problem", Ther Adv Drug Saf, 5, pp.229~241 (2014)[DOI]
31. Wright GD, "New strategies for combating multidrug-resistant bacteria", Trends Mol Med, 13, pp.260~267 (2007)[DOI]
32. Alonso A, "Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa", Microbiology, 145, pp.2857~2862 (1999)[DOI]
33. Terreni M, "New antibiotics for multidrug-resistant bacterial strains : latest research developments and future perspectives", Molecules, 26, pp.2671~ (2021)[DOI]
34. Brooks L, "Prevalence of antibiotic resistance genes in the oral cavity and mobile genetic elements that disseminate antimicrobial resistance : a systematic review", Mol Oral Microbiol, 37, pp.133~153 (2022)[DOI]
35. Demain AL, "Antibiotics : natural products essential to human health", Med Res Rev, 29, pp.821~842 (2009)[DOI]
36. Demain AL, "Importance of microbial natural products and the need to revitalize their discovery", J Ind Microbiol Biotechnol, 41, pp.185~201 (2014)[DOI]
37. Moloney MG, "Natural products as a source for novel antibiotics", Trends Pharmacol Sci, 37, pp.689~701 (2016)[DOI]
38. Mehbub MF, "New marine natural products from sponges(Porifera)of the order Dictyoceratida(2001 to 2012); a promising source for drug discovery, exploration and future prospects", Biotechnol Adv, 34, pp.473~491 (2016)[DOI]
39. Stonik VA, "Antibiotics from marine bacteria", Biochemistry (Mosc), 85, pp.1362~1373 (2020)[DOI]
40. Fiedler HP, "Marine actinomycetes as a source of novel secondary metabolites", Antonie Van Leeuwenhoek, 87, pp.37~42 (2005)[DOI]
41. Jagannathan SV, "Marine actinomycetes, new sources of biotechnological products", Mar Drugs, 19, pp.365~ (2021)[DOI]
42. Deng Y, "Marine natural products and their synthetic analogs as promising antibiofilm agents for antibiotics discovery and development", Eur J Med Chem, 239, pp.114513~ (2022)[DOI]
43. Liu M, "Antibacterial activity and mechanisms of depolymerized fucoidans isolated from Laminaria japonica", Carbohydr Polym, 172, pp.294~305 (2017)[DOI]
44. Oka S, "Properties of fucoidans beneficial to oral healthcare", Odontology, 108, pp.34~42 (2020)[DOI]
45. Senthilkumar K, "Brown seaweed fucoidan : biological activity and apoptosis, growth signaling mechanism in cancer", Int J Biol Macromol, 60, pp.366~374 (2013)[DOI]
46. Fitton JH, "Therapies from fucoidan; multifunctional marine polymers", Mar Drugs, 9, pp.1731~1760 (2011)[DOI]
47. de A. Lima B, "Halistanol sulfate A and rodriguesines A and B are antimicrobial and antibiofilm agents against the cariogenic bacterium Streptococcus mutans", Rev Bras Farmacogn, 24, pp.651~659 (2014)[DOI]
48. Fusetani N, "Bioactive marine metabolites II. Halistanol sulfate, an antimicrobial novel steroid sulfate from the marine sponge Halichondria cf. Moorei bergquist", Tetrahedron Lett, 22, pp.1985~1988 (1981)[DOI]
49. Schneemann I, "Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea", J Nat Prod, 73, pp.1309~1312 (2010)[DOI]
50. "J Antibiot (Tokyo)", 2009, 519~526, 10.1038[DOI]
51. Sabido EM, "Marine sediment-derived Streptomyces strain produces angucycline antibiotics against multidrug-resistant Staphylococcus aureus harboring SCCmec type 1 gene", J Mar Sci Eng, 8, pp.734~ (2020)[DOI]
52. Radjasa OK, "Antibacterial activity of marine bacterium Pseudomonas sp. Associated with soft coral Sinularia polydactyla against Streptococcus equi subsp. Zooepidemicus", Int J Pharmacol, 3, pp.170~174 (2007)[DOI]
53. Noga EJ, "Primary structure and cellular localization of callinectin, an antimicrobial peptide from the blue crab", Dev Comp Immunol, 35, pp.409~415 (2011)[DOI]
54. Fernández-Peña L, "Recent advances in biologically active coumarins from marine sources : synthesis and evaluation", Mar Drugs, 21, pp.37~ (2023)[DOI]
55. He Z, "Anti-biofilm activities of coumarin as quorum sensing inhibitor for Porphyromonas gingivalis", J Oral Microbiol, 14, pp.2055523~ (2022)[DOI]
56. Wright CJ, "Disruption of heterotypic community development by Porphyromonas gingivalis with small molecule inhibitors", Mol Oral Microbiol, 29, pp.185~193 (2014)[DOI]
57. Abdelmohsen UR, "Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections", Lancet Infect Dis, 17, pp.e30~e41 (2017)[DOI]
58. Kumar R, "Aurantoside K, a new antifungal tetramic acid glycoside from a Fijian marine sponge of the genus Melophlus", Mar Drugs, 10, pp.200~208 (2012)[DOI]
59. Sbordone L, "Oral microbial biofilms and plaque-related diseases : microbial communities and their role in the shift from oral health to disease", Clin Oral Investig, 7, pp.181~188 (2003)[DOI]
60. Kilian M, "The oral microbiome-friend or foe?", Eur J Oral Sci, 126, pp.5~12 (2018)[DOI]
61. Sultan AS, "The oral microbiome : a lesson in coexistence", PLoS Pathog, 14, pp.e1006719~ (2018)[DOI]
62. Dewhirst FE, "The human oral microbiome", J Bacteriol, 192, pp.5002~5017 (2010)[DOI]
63. Baty JJ, "Oral commensal streptococci : gatekeepers of the oral cavity", J Bacteriol, 204, pp.e0025722~ (2022)[DOI]
64. Hutcherson JA, "Amixicile, a novel strategy for targeting oral anaerobic pathogens", Sci Rep, 7, pp.10474~ (2017)[DOI]
65. Gui Q, "Amixicile targets anaerobic bacteria within the oral microbiome", J Oral Biosci, 61, pp.226~235 (2019)[DOI]
66. Pérot S, "Druggable pockets and binding site centric chemical space : a paradigm shift in drug discovery", Drug Discov Today, 15, pp.656~667 (2010)[DOI]
67. Stone VN, "Targeted antimicrobial therapy in the microbiome era", Mol Oral Microbiol, 32, pp.446~454 (2017)[DOI]
68. Soga S, "Use of amino acid composition to predict ligand-binding sites", J Chem Inf Model, 47, pp.400~406 (2007)[DOI]
69. Fuqua WC, "Quorum sensing in bacteria : the LuxR-LuxI family of cell density-responsive transcriptional regulators", J Bacteriol, 176, pp.269~275 (1994)[DOI]
70. Shao H, "Quorum sensing regulation of biofilm growth and gene expression by oral bacteria and periodontal pathogens", Periodontol 2000, 52, pp.53~67 (2010)[DOI]
71. Niazy AA, "LuxS quorum sensing system and biofilm formation of oral microflora : a short review article", Saudi Dent J, 33, pp.116~123 (2021)[DOI]
72. Stewart PS, "Antibiotic resistance of bacteria in biofilms", Lancet, 358, pp.135~138 (2001)[DOI]
73. Høiby N, "Antibiotic resistance of bacterial biofilms", Int J Antimicrob Agents, 35, pp.322~332 (2010)[DOI]
74. Jenkinson HF, "Structure, function and immunogenicity of streptococcal antigen I", II polypeptides, 1997, pp.23, 183~190
75. Ahn SJ, "Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva", Infect Immun, 76, pp.4259~4268 (2008)[DOI]
76. Arciola CR, "Polysaccharide intercellular adhesin in biofilm : structural and regulatory aspects", Front Cell Infect Microbiol, 5, pp.7~ (2015)[DOI]
77. Sharma A, "Synergy between Tannerella forsythia and Fusobacterium nucleatum in biofilm formation", Oral Microbiol Immunol, 20, pp.39~42 (2005)[DOI]
78. Okuda T, "Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species", Anaerobe, 18, pp.110~116 (2012)[DOI]
79. Sarangi AN, "Subtractive genomics approach for in silico identification and characterization of novel drug targets in Neisseria meningitides serogroup B", J Comput Sci Syst Biol, 2, pp.255~258 (2009)[DOI]
80. Gerits E, "New approaches to combat Porphyromonas gingivalis biofilms", J Oral Microbiol, 9, pp.1300366~ (2017)[DOI]
81. Rasmussen TB, "Quorum-sensing inhibitors as anti-pathogenic drugs", Int J Med Microbiol, 296, pp.149~161 (2006)[DOI]
82. Haque S, "Developments in strategies for quorum sensing virulence factor inhibition to combat bacterial drug resistance", Microb Pathog, 121, pp.293~302 (2018)[DOI]
83. Chung WO, "Signaling system in Porphyromonas gingivalis based on a LuxS protein", J Bacteriol, 183, pp.3903~3909 (2001)[DOI]
84. Frias J, "Periodontal pathogens produce quorum sensing signal molecules", Infect Immun, 69, pp.3431~3434 (2001)[DOI]
85. Kolenbrander PE, "Bacterial interactions and successions during plaque development", Periodontol 2000, 42, pp.47~79 (2006)[DOI]
86. Jang YJ, "Autoinducer 2of Fusobacterium nucleatum as a target molecule to inhibit biofilm formation of periodontopathogens", Arch Oral Biol, 58, pp.17~27 (2013)[DOI]
87. Senadheera D, "Quorum sensing and biofilm formation by Streptococcus mutans", Adv Exp Med Biol, 631, pp.178~188 (2008)[DOI]
88. Shao H, "Autoinducer 2 is required for biofilm growth of Aggregatibacter(Actinobacillus)actinomycetemcomitans", Infect Immun, 75, pp.4211~4218 (2007)[DOI]
89. Cho YJ, "In vivo inhibition of Porphyromonas gingivalis growth and prevention of periodontitis with quorum-sensing inhibitors", J Periodontol, 87, pp.1075~1082 (2016)[DOI]
90. Ryu EJ, "D-galactose as an autoinducer 2 inhibitor to control the biofilm formation of periodontopathogens", J Microbiol, 54, pp.632~637 (2016)[DOI]
91. An SJ, "Inhibitory effect of D-arabinose on oral bacteria biofilm formation on titanium discs", Anaerobe, 75, pp.102533~ (2022)[DOI]
92. Park T, "Short-chain fatty acids inhibit the biofilm formation of Streptococcus gordonii through negative regulation of competence-stimulating peptide signaling pathway", J Microbiol, 59, pp.1142~1149 (2021)[DOI]
93. Park JS, "New bicyclic brominated furanones as potent autoinducer-2 quorumsensing inhibitors against bacterial biofilm formation", Eur J Med Chem, 137, pp.76~87 (2017)[DOI]
94. Chen Y, "Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro", PLoS One, 11, pp.e0153468~ (2016)[DOI]
95. He Z, "Use of the quorum sensing inhibitor furanone C-30 to interfere with biofilm formation by Streptococcus mutans and its luxS mutant strain", Int J Antimicrob Agents, 40, pp.30~35 (2012)[DOI]

관련 논문AI추천